INTRODUCTION According to a study published in the Canadian Journal of Infectious Disease and Medical Microbiology in 2021, more than 1. 3 million cases of needlestick injuries (NSI) among health care workers (HCWs) are reported every year in the US and Europe.
New York, July 15, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Needlestick Safety Injection Devices Market by Type of Device, Purpose of Device, Usability, Company Size and Key Geographical Regions : Industry Trends and Global Forecasts, 2022-2035" - https://www.reportlinker.com/p06292887/?utm_source=GNW NSIs are known to occur frequently in healthcare settings while using injections and can lead to transmission of various blood borne pathogen. In fact, as per the estimates provided by the Centers for Disease Control and Prevention (CDC), HCWs are at an increased risk of exposure to harmful pathogens, such as human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus, due to needlesticks. Some of the common factors that are believed to be the cause for high number of NSIs include inessential use of sharp devices, inadequacy of personal protective equipment, lack of training, and inappropriate disposal of sharp devices and needles. In order to reduce the number of such cases, several initiatives have been undertaken to ensure safety of HCWs and patients, which include the launch of 2010 EU directive initiative on sharps injury prevention by the European Union and development of smart needles and advanced injection devices. Since the use of needles is unavoidable in healthcare, device developers have come up with highly advanced product designs and safety measurements to limit the risk posed by sharp needles. These safety injection devices have several advantages, including needle shielding and automatic retraction of needles into the syringe barrel when the plunger is released, and easy disposal of safety needle. Given the various benefits of needlestick safety injection devices, several companies have developed and launched their proprietary smart devices that are capable of preventing injuries caused by needlesticks along with reducing the transmission of infectious diseases. In addition, in order to expand the reach of their devices and enhance their product portfolios, players in this domain are actively collaborating with other stakeholders. Moreover, the stakeholders have undertaken several initiatives to augment their intellectual portfolio with an intention to incorporate advanced features to their products. Driven by the growing demand for safe and efficient drug delivery systems and ongoing efforts by the players to integrate sophisticated features in the product design and technology, the needlestick safety injection devices market is likely to witness noteworthy growth over the coming years. SCOPE OF THE REPORT The “Needlestick Safety Injection Devices Market by Type of Device (Needles, Syringes, and Other types of devices), Purpose of Device (Needle Shielding, Protection against Injuries, and Enabling ease of Needle Insertion / Retraction), Usability (Non-Reusable and Reusable), Company Size (Very Large, Large, Mid-sized, Small and Very Small) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035” report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of the needlestick safety injection devices (either commercialized or under development) in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes: A detailed assessment of the market landscape of needlestick safety injection devices based on several relevant parameters, such as type of device (needle, syringe, and other types of devices), purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding), usability (non-reusable and reusable), mode of sterilization (ethylene oxide, gamma rays, steam and other methods) and packaging format (box, tub, and other packaging formats). In addition, it features analysis of the companies engaged in the development / deployment of needlestick safety injection devices, along with information on their year of establishment, company size, location of headquarters, and leading players (in terms of number of needlestick safety injection devices developed). An in-depth key insights analysis, highlighting the contemporary market trends using impactful schematic representations, including a tree map representation, based on type of device (needle, syringe, and other types of devices) and company size, a waffle chart representation, based on purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding) and company size, a 4D bubble analysis, which compares the capabilities of leading players engaged in the development / deployment of needlestick safety injection devices, based on various parameters, such as type of device (needle, syringe, and other types of devices), purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding), company size and location of headquarters (region-wise), a world map representation, highlighting the regional distribution of leading players engaged in the development / deployment of needlestick safety injection devices and a grid representation, based on type of device, purpose of device and usability. A detailed product competitiveness analysis of needlestick safety injection devices, based on supplier power (based on the experience of the developer in this industry) and key specifications of products, including purpose of device (enabling ease of needle insertion / retraction, protection against injuries and needle shielding), usability (non-reusable and reusable), mode of sterilization (gamma rays, ethylene oxide, steam, and other methods). An in-depth analysis of various initiatives undertaken in this domain, during the period 2016-2022, wherein companies have entered into partnerships with other stakeholders related to needlestick safety injection devices and the related recent events (conferences / seminars / webinars / workshops) organized by several stakeholders, across the globe. In addition, it provides information on the funding activity in this domain, highlighting the involvement of venture capitalists and funding schemes of various public and private organizations / funds that have allowed start-ups / small companies to expand their capabilities. An analysis of the patents filed / granted for needlestick safety injection devices, since 2018, taking into consideration several relevant parameters, such as type of patent, publication year, application year, issuing authority, geographical location, Cooperative Patent Classification (CPC) symbols, emerging focus areas, type of organization, leading industry and non-industry players (on the basis of number of patents filed / granted) and individual patent assignees (in terms of size of intellectual property portfolio), patent benchmarking, patent characteristics and age of patents. In addition, the chapter also includes an insightful patent valuation analysis and leading patents by number of citations. Elaborate profiles of key players engaged in the development of needlestick safety injection devices. Each profile features a brief overview of the company, details on its product portfolio, recent developments and an informed future outlook. Additionally, it provides a detailed scoring matrix of leading players profiled in this chapter (based on the recent initiatives). A Bowman’s strategy clock framework to understand the pricing strategy of the needlestick safety injection devices developed by the company along with its competitive position in the marketplace. In addition, it presents the equation devised to calculate the likely price of the needlestick safety injection devices based upon their features. One of the key objectives of the report was to evaluate the existing market size, primary growth factors and future opportunity within the needlestick safety injection devices market in the mid to long term. Our year-wise projections of the current and future opportunity within the needlestick safety injection devices market have further been segmented across types of devices (needles, syringes, and other types of devices), purposes of devices (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding), usability (reusable and non-reusable), company size of developers (very small, small, mid-sized, large and very large) and geographical regions (North America, Europe, Asia-Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth. All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified. RESEARCH METHODOLOGY The data presented in this report has been gathered via secondary research. For all our projects, we conduct interviews / surveys with experts in the area (academia, industry and other associations) to solicit their opinions on emerging trends in the market. This information is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been validated from multiple sources of information. The secondary sources of information include: Annual reports Investor presentations SEC filings Industry databases News releases from company websites Government policy documents Industry analysts’ views While the focus has been on forecasting the market till 2035, the report also provides our independent views on various non-commercial trends emerging in this industry. The opinions are solely based on our knowledge, research and understanding of the relevant market trends gathered from various secondary and primary sources of information. KEY QUESTIONS ANSWERED Who are the leading players engaged in the development of needlestick safety injection devices? Which are the popular types of safety injection devices available in the market? What are the key challenges associated with the development of needlestick safety injection devices? Which type of partnership models are commonly being adopted by industry stakeholders? How has the intellectual property landscape of needlestick safety injection devices developers evolved over the years? What factors are likely to influence the evolution of this market? How is the current and future market opportunity likely to be distributed across key market segments? CHAPTER OUTLINES Chapter 2 is an executive summary of the key insights captured during our research. It offers a high-level view on the current state of the needlestick safety injection devices market and its likely evolution in the mid to long term. Chapter 3 provides a general introduction to needlestick safety injection devices, types of needle-stick safety injection devices and their advantages. In addition, the chapter provides an overview on the growing relevance of the safety injection devices, as potential solutions to limit the injuries caused by the use of conventional needles. Further, the chapter presents an array of Google trends analysis, highlighting the emerging focus areas, key historical trends, and geographical activity, offering insights on how this field has evolved over the last five years. Chapter 4 presents a detailed assessment of the market landscape of around 140 needlestick safety injection devices, based on several relevant parameters, such as type of device (needle, syringe, and other types of devices), purpose of devices (enabling ease of needle insertion / retraction, protection against injuries and needle shielding), usability (reusable and non-reusable), mode of sterilization (ethylene oxide, gamma rays, steam and other methods), and packaging format (box, tub, and other packaging formats). In addition, it presents analysis on the companies engaged in the development / deployment of needlestick safety injection devices, along with information on their year of establishment, company size, location of headquarters. Further, it highlights the leading players (in terms of number of needlestick safety injection devices developed) in this domain. Chapter 5 presents an in-depth key insights analysis, highlighting the contemporary market trends using impactful schematic representations, including [A] a tree map representation, based on type of device (needle, syringe, and other types of devices) and company size, [B] a waffle chart representation, based on purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding) and company size, [C] a 4D bubble analysis, which compares the capabilities of leading players engaged in the development / deployment of needlestick safety injection devices, based on various parameters, such as type of device (needle, syringe, and other types of devices), purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding), company size and location of headquarters (region-wise), [D] a world map representation, highlighting the regional distribution of leading players engaged in the development / deployment of needlestick safety injection devices and [E] a grid representation, based on type of device, purpose of device and usability. Chapter 6 is an insightful product competitiveness analysis of needlestick safety injection devices, based on supplier power (based on the experience of the developer in this industry) and key specifications of products, including purpose of device (enabling ease of needle insertion / retraction, protection against injuries and needle shielding), usability (non-reusable and reusable), and mode of sterilization (ethylene oxide, gamma, steam, and other methods). Chapter 7 features an in-depth analysis of various initiatives undertaken in this domain, during the period 2016-2022, wherein companies have entered into partnerships with other stakeholders related to needlestick safety injection devices and the related recent events (conferences / seminars / webinars / workshops) organized by several stakeholders, across the globe. In addition, it provides information on the funding activity in this domain, highlighting the involvement of venture capitalists and funding schemes of various public and private organizations / funds that have allowed start-ups / small companies to expand their capabilities. Chapter 8 provides an insightful analysis of the patents filed / granted for needlestick safety injection devices, since 2018, taking into consideration several relevant parameters, such as type of patent, publication year, application year, issuing authority, geographical location, Cooperative Patent Classification (CPC) symbols, emerging focus areas, leading industry and non-industry players (on the basis of number of patents) and individual patent assignees (in terms of size of intellectual property portfolio), patent benchmarking, patent characteristics and age of patents. In addition, the chapter also includes an insightful patent valuation analysis and leading patents by number of citations. Chapter 9 provides detailed profiles of key players engaged in the development of needlestick safety injection devices. Each profile features a brief overview of the company, details on its product portfolio, recent developments and an informed future outlook. Additionally, it provides a detailed scoring matrix of leading players profiled in this chapter (based on the recent initiatives). Chapter 10 presents a Bowman’s strategy clock framework to understand the pricing strategy of the needlestick safety injection devices developed by the company along with its competitive position in the marketplace. In addition, it presents the equation devised to calculate the likely price of the needlestick safety injection devices based upon their features. Chapter 11 features an insightful market forecast analysis, highlighting the likely growth of the needlestick safety injection devices market, till the year 2035. In addition, we estimated the likely distribution of the current and forecasted opportunity across various types of devices (needles, syringes, and other types of devices), purposes of devices (needle shielding, protection against injuries, and enabling ease of needle insertion / retraction), usability (non-reusable and reusable), company size of developers (very large, large, mid-sized, small and very small) and geographical regions (North America, Europe, Asia-Pacific and rest of the world). Chapter 12 is a summary of the overall report, highlighting various facts related to contemporary market trend and the likely evolution of the needlestick safety injection devices market. Chapter 13 is an appendix that contains tabulated data and numbers for all the figures in the report. Chapter 14 is an appendix that provides the list of companies and organizations mentioned in the report. Read the full report: https://www.reportlinker.com/p06292887/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
(Reuters) -The judge overseeing Twitter Inc's $44 billion lawsuit against Elon Musk has a no-nonsense reputation as well as the distinction of being one of the few jurists who has ever ordered a reluctant buyer to close a U.S. corporate merger. Kathaleen McCormick took over the role of chancellor or chief judge of the Court of Chancery last year, the first woman in that role. On Wednesday, she was assigned the Twitter lawsuit which seeks to force Musk to complete his deal for the social media platform, which promises to be one of the biggest legal showdowns in years.
Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) is joining its tech peers in a stock split. The trillion-dollar tech giant, which is the parent company of Google, plans to do a 20:1 stock split on Friday, July 15. If you're aiming to buy Alphabet before the stock split, the clock is ticking.
Rogers knows how to survive — and thrive — in turbulent times.
The market is unstable. Your portfolio doesn’t need to be.
Intel ( ) is the bearer of additional bad news. The chip giant will give an extra blow to consumers and businesses concerned about the health of the economy. For several weeks in fact, consumers have seen their bills for groceries and other products increase.
The deal talks are still on track but coming data and arbitration slowed the timeline, people familiar with the matter say.
To the oil industry, there is no single price of oil. Instead, there are multiple like Brent, Dubai, and WTI, each for a particular grade of crude. Russia has its own grade of oil—and its price is languishing.
Yahoo Finance Live checks out several of the day's trending stocks, including UnitedHealth Group's profit beat and gaming stocks popping off after an influx of Tiger Woods sports bets.
Shares of some of the world's biggest technology companies gained ground on Friday after several difficult sessions for the market. Semiconductor specialist Nvidia (NASDAQ: NVDA) was up as much as 2.4%, social media giant Meta Platforms (NASDAQ: META) rose as much as 3.7%, and customer relationship management (CRM) specialist Salesforce (NYSE: CRM) climbed as much as 3.8%. The catalyst that sent a wide swath of technology stocks higher today was a read on consumer spending, which was more robust than many had predicted.
Goldman Sachs slashed its earnings forecast for chipmakers and semiconductors due to fears of a slowdown in global growth.
(Bloomberg) -- Carson Block was on a Delta flight to New York when he felt blood pooling on his seat.Most Read from BloombergIvana Trump, First Wife of Former President, Dies At 73Chinese Homebuyers Across 22 Cities Refuse to Pay MortgagesBiden to Leave Mideast With No Immediate Announcement on OilTrump Allies Line Up Shadow Government, Mindful of 2016’s ChaosIt’s a tale the famous, filter-free founder of trading firm Muddy Waters Capital launches into to make a point about misdoings among short
Russia is positioning itself to engage in 'expropriation blackmail,' according to Mark Dixon, founder of the Moral Rating Agency.
The head of the company now running the former McDonald's Corp chain of restaurants in Russia told RBC TV that producers of French fries are refusing to supply to the country and warned that attempts to increase domestic processing are fraught with difficulties. McDonald's quit Russia after a Western backlash against Moscow's military campaign in Ukraine, which included a barrage of economic sanctions, and sold all the restaurants it owned to a local licensee in May. CEO Oleg Paroev told Reuters the chain had sold almost 120,000 burgers on opening day.
Mining stocks could capitulate given waning demand for industrial metals
Every investor wants to see his stocks pay off – or he wouldn’t be in the markets. But finding the right investment, the ‘one’ that will bring profits, can sometimes be challenging, especially in today's market conditions. The two simplest courses of action an investor can take to ensure solid returns are based on common sense. The first is to buy low and sell high. That is, find a cheap stock with sound fundamentals and good prospects for growth – and buy in to take advantage of the growth pote
Most retired workers depend on multiple streams of income during their retirement. Two of the most common such income streams are Social Security and pensions. If we look at pension vs. Social Security income, we find significant differences. Retired workers … Continue reading → The post Pension vs. Social Security: Key Differences appeared first on SmartAsset Blog.
Bill Gates has promised to give "virtually all" of his fortune away. Where will it go?
(Bloomberg) -- Former Treasury Secretary Lawrence Summers issued one of his harshest criticisms yet of the Federal Reserve’s slowness in moving to raise interest rates, and warned that policy makers are still presenting forecasts that are unrealistic.Most Read from BloombergIvana Trump, First Wife of Former President, Dies At 73Chinese Homebuyers Across 22 Cities Refuse to Pay MortgagesBiden to Leave Mideast With No Immediate Announcement on OilTrump Allies Line Up Shadow Government, Mindful of
Home sale cancellations soared in June. But why?
Alphabet stock will undergo a 20-for-1 stock split on July 18. Here's how to trade the stock into the event.